Li N - Search Results

1

Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MS.

Li YZ, Hu CJ, Leng XM, Zhao GF, Li N, Xu Y. Li YZ, et al. Among authors: li n. Anat Rec (Hoboken). 2009 Mar;292(3):455-60. doi: 10.1002/ar.20870. Anat Rec (Hoboken). 2009. PMID: 19248174 Free article.

2

[The contribution for the diagnosis of the tumor-like polypoid lesions of the gallbladder by SELDI-TOF-MS].

Luan FM, Ge CL, Ma N, Li YZ, Hu CJ, Li N. Luan FM, et al. Among authors: li yz, li n. Zhonghua Wai Ke Za Zhi. 2008 Apr 1;46(7):525-7. Zhonghua Wai Ke Za Zhi. 2008. PMID: 18785564 Chinese.

3

Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.

Wang QT, Li YZ, Liang YF, Hu CJ, Zhai YH, Zhao GF, Zhang J, Li N, Ni AP, Chen WM, Xu Y. Wang QT, et al. Among authors: li yz, li n. Anat Rec (Hoboken). 2009 Apr;292(4):604-10. doi: 10.1002/ar.20871. Anat Rec (Hoboken). 2009. PMID: 19301277 Free article.

4

[Effects of berbamine on the isolated myocardium in guinea pigs and humans].

Li NY, Li WH, Li Y. Li NY, et al. Among authors: li y, li wh. Zhongguo Yao Li Xue Bao. 1986 May;7(3):222-6. Zhongguo Yao Li Xue Bao. 1986. PMID: 2954366 Free article. Chinese. No abstract available.

5

Prediction of progesterone receptor expression in high-grade meningioma by using radiomics based on enhanced T1WI.

Duan C, Li N, Li Y, Cui J, Xu W, Liu X. Duan C, et al. Among authors: li y, li n. Clin Radiol. 2023 Oct;78(10):e752-e757. doi: 10.1016/j.crad.2023.06.006. Epub 2023 Jun 28. Clin Radiol. 2023. PMID: 37487839

6

[Deepening the Action on Salt Reduction in China-suggestions on strategy and implementation plan].

Wang LD, Zhang PH, Li Y, Li YH, Zhang B, Wang HJ, Wu J, Han JH, Li CN, Li N, Li XH, Ding GG, Wu ZS. Wang LD, et al. Among authors: li yh, li xh, li y, li n, li cn. Zhonghua Yu Fang Yi Xue Za Zhi. 2023 Jul 6;57(7):1105-1114. doi: 10.3760/cma.j.cn112150-20221205-01176. Zhonghua Yu Fang Yi Xue Za Zhi. 2023. PMID: 37190746 Chinese.

7

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.

EMPA-KIDNEY Collaborative Group. EMPA-KIDNEY Collaborative Group. Lancet Diabetes Endocrinol. 2024 Jan;12(1):39-50. doi: 10.1016/S2213-8587(23)00321-2. Epub 2023 Dec 4. Lancet Diabetes Endocrinol. 2024. PMID: 38061371 Free PMC article. Clinical Trial.

8

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.

EMPA-KIDNEY Collaborative Group. EMPA-KIDNEY Collaborative Group. Lancet Diabetes Endocrinol. 2024 Jan;12(1):51-60. doi: 10.1016/S2213-8587(23)00322-4. Epub 2023 Dec 4. Lancet Diabetes Endocrinol. 2024. PMID: 38061372 Free article. Clinical Trial.

9

[Analysis of 10 cases of brentuximab vedotin combined with chemotherapy in the treatment of children with refractory and or relapsed classic Hodgkin lymphoma].

Li N, Li Y, Zhou CJ, Huang S, Jin L, Yang J, Shao MM, Sun H, Wang XL, Duan YL. Li N, et al. Among authors: li y. Zhonghua Er Ke Za Zhi. 2024 Aug 2;62(8):775-779. doi: 10.3760/cma.j.cn112140-20240615-00399. Zhonghua Er Ke Za Zhi. 2024. PMID: 39039881 Chinese.

10

Relationship between dietary patterns and diabetic microvascular complications in patients with type 2 diabetes mellitus.

Liu YJ, Wang Y, Xu LX, Yang J, Zhao Y, Qiao J, Li N, Li Y, Lv DQ, Sun WY. Liu YJ, et al. Among authors: li y, li n. Eur Rev Med Pharmacol Sci. 2023 Sep;27(18):8780-8794. doi: 10.26355/eurrev_202309_33800. Eur Rev Med Pharmacol Sci. 2023. PMID: 37782205 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,890 results

Search Page

Filters